earnings
confidence high
sentiment negative
materiality 0.80
Bausch + Lomb Q2 revenue $1.216B (+17% YoY); GAAP net loss $151M; raises FY2024 guidance
Bausch & Lomb Corp
2024-Q2 EPS reported
-$0.90
revenue$2,315,000,000
- Revenue $1.216B, up 17% reported and 20% constant currency vs Q2 2023.
- GAAP net loss attributable to BLCO $151M; adjusted EPS $0.13 (vs $0.18 a year ago).
- Pharmaceuticals segment revenue surged 60% YoY to $310M, driven by XIIDRA acquisition and MIEBO launch.
- Raised FY2024 revenue guidance to $4.7-4.8B (prev $4.6-4.7B) and adjusted EBITDA to $850-900M.
- Adjusted EBITDA (non-GAAP) $209M, up from $179M in Q2 2023.